164 related articles for article (PubMed ID: 36854589)
1. Characterisation of medical conditions of children with sickle cell disease in the USA: findings from the 2007-2018 National Health Interview Survey (NHIS).
Gyamfi J; Tampubolon S; Lee JT; Islam F; Ojo T; Opeyemi J; Qiao W; Mai A; Wang C; Vieira D; Ryan N; Osei-Tutu NH; Adenikinju D; Meda S; Ogedegbe G; Peprah E
BMJ Open; 2023 Feb; 13(2):e069075. PubMed ID: 36854589
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the 2007-2018 National Health Interview Survey (NHIS): Examining Neurological Complications among Children with Sickle Cell Disease in the United States.
Peprah E; Gyamfi J; Lee JT; Islam F; Opeyemi J; Tampubolon S; Ojo T; Qiao W; Mai A; Wang C; Vieira D; Meda S; Adenikinju D; Osei-Tutu N; Ryan N; Ogedegbe G
Int J Environ Res Public Health; 2023 Jun; 20(12):. PubMed ID: 37372724
[TBL] [Abstract][Full Text] [Related]
3. Health status and healthcare use in a national sample of children with sickle cell disease.
Boulet SL; Yanni EA; Creary MS; Olney RS
Am J Prev Med; 2010 Apr; 38(4 Suppl):S528-35. PubMed ID: 20331954
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Substance Use Disorders in Sickle Cell Disease Compared to Other Chronic Conditions: a Population-Based Study of Black American Adults.
Jonassaint CR; O'Brien J; Nardo E; Feldman R; Stanton M; DeCastro L; Abebe KZ
J Gen Intern Med; 2023 Apr; 38(5):1214-1223. PubMed ID: 36220945
[TBL] [Abstract][Full Text] [Related]
6. Differences in the prevalence of mental health disorders among Black American adults with sickle cell disease compared to those with non-heritable medical conditions or no medical conditions.
Jonassaint CR; Lukombo I; Feldman R; Driscoll J; Eack SM; Abebe KZ; De Castro L
Br J Haematol; 2022 Feb; 196(4):1059-1068. PubMed ID: 34859423
[TBL] [Abstract][Full Text] [Related]
7. Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018.
Early ML; Eke AC; Gemmill A; Lanzkron S; Pecker LH
JAMA Netw Open; 2023 Feb; 6(2):e2254552. PubMed ID: 36729452
[TBL] [Abstract][Full Text] [Related]
8. Academic attainment findings in children with sickle cell disease.
Epping AS; Myrvik MP; Newby RF; Panepinto JA; Brandow AM; Scott JP
J Sch Health; 2013 Aug; 83(8):548-53. PubMed ID: 23834606
[TBL] [Abstract][Full Text] [Related]
9. The impact of race and disease on sickle cell patient wait times in the emergency department.
Haywood C; Tanabe P; Naik R; Beach MC; Lanzkron S
Am J Emerg Med; 2013 Apr; 31(4):651-6. PubMed ID: 23380119
[TBL] [Abstract][Full Text] [Related]
10. Social Determinants of Health and Emergency Department Use Among Children With Sickle Cell Disease.
Cortright L; Buckman C; Tumin D; Holder D; Leonard S
J Pediatr Hematol Oncol; 2020 Jan; 42(1):e42-e45. PubMed ID: 31743315
[TBL] [Abstract][Full Text] [Related]
11. Health of children in title XXI: should we worry?
Stein RE; Shenkman E; Wegener DH; Silver EJ
Pediatrics; 2003 Aug; 112(2):e112-8. PubMed ID: 12897316
[TBL] [Abstract][Full Text] [Related]
12. Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.
Payne AB; Link-Gelles R; Azonobi I; Hooper WC; Beall BW; Jorgensen JH; Juni B; Moore M;
Pediatr Infect Dis J; 2013 Dec; 32(12):1308-12. PubMed ID: 23811745
[TBL] [Abstract][Full Text] [Related]
13. Caries prevalence and impact on oral health-related quality of life in children with sickle cell disease: cross-sectional study.
Fernandes ML; Kawachi I; Corrêa-Faria P; Pattusi MP; Paiva SM; Pordeus IA
BMC Oral Health; 2015 Jun; 15():68. PubMed ID: 26085066
[TBL] [Abstract][Full Text] [Related]
14. Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability - Sickle Cell Data Collection Program, 11 States, 2016-2020.
Kayle M; Blewer AL; Pan W; Rothman JA; Polick CS; Rivenbark J; Fisher E; Reyes C; Strouse JJ; Weeks S; Desai JR; Snyder AB; Zhou M; Sutaria A; Valle J; Horiuchi SS; Sontag MK; Miller JI; Singh A; Dasgupta M; Janson IA; Galadanci N; Reeves SL; Latta K; Hurden I; Cromartie SJ; Plaxco AP; Mukhopadhyay A; Smeltzer MP; Hulihan M
MMWR Morb Mortal Wkly Rep; 2024 Mar; 73(12):248-254. PubMed ID: 38547025
[TBL] [Abstract][Full Text] [Related]
15. Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry.
Mendez GG; Nocek JM; Brambilla DJ; Jacobs S; Cole O; Kanter J; Glassberg J; Saving KL; Melvin CL; Gibson RW; Treadwell M; Jackson GL; King AA; Gordeuk VR; Kroner B; Hsu LL;
BMC Health Serv Res; 2024 Mar; 24(1):291. PubMed ID: 38448911
[TBL] [Abstract][Full Text] [Related]
16. Maternal Educational Attainment and Child Health in the United States.
Lawrence EM; Rogers RG; Hummer RA
Am J Health Promot; 2020 Mar; 34(3):303-306. PubMed ID: 31833396
[TBL] [Abstract][Full Text] [Related]
17. Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.
Peterson EE; Salemi JL; Dongarwar D; Salihu HM
Eur J Pediatr; 2020 Nov; 179(11):1701-1710. PubMed ID: 32394268
[TBL] [Abstract][Full Text] [Related]
18. Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.
Zhou J; Han J; Nutescu EA; Galanter WL; Walton SM; Gordeuk VR; Saraf SL; Calip GS
Br J Haematol; 2019 Apr; 185(1):116-127. PubMed ID: 30714090
[TBL] [Abstract][Full Text] [Related]
19. Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease.
Nelson MD; Bennett DM; Lehman ME; Okonji AI
Am J Audiol; 2022 Dec; 31(4):1178-1190. PubMed ID: 36251873
[TBL] [Abstract][Full Text] [Related]
20. Impact of Race, Socioeconomic Status, and Geography on Healthcare Outcomes for Children With Sickle Cell Disease in the United States: A Scoping Review.
Wahab S; Kelly K; Klingler M; Pirovic A; Futch K; Rennie C; Durham D; Herber D; Gramling G; Price S; Costin JM
Cureus; 2024 Mar; 16(3):e56089. PubMed ID: 38618364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
